Buck S. Samuel, et.al., Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41., Proceedings of the National Academy of Sciences of the United States of America, 2008, 105

http://rdf.ncbi.nlm.nih.gov/pubmed/18931303

Buck S. Samuel, et.al., Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41., Proceedings of the National Academy of Sciences of the United States of America, 2008, 105

pubmed

BRC マウスの系統

http://purl.org/net/cito/citesAsAuthority

• B6;129-Ffar3<tm1Reh>
  http://metadb.riken.jp/db/rikenbrc_mouse/RBRC06327

Class

http://purl.org/net/cito/citesAsAuthority

• B6;129-Ffar3<tm1Reh>
  http://metadb.riken.jp/db/rikenbrc_mouse/RBRC06327

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• abnormal intestinal transit time in RBRC06327
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1009828
• decreased triglyceride level in RBRC06327
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1009825
• abnormal feces composition in RBRC06327
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1009824
• abnormal energy homeostasis in RBRC06327
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1009826
• homeostasis/metabolism phenotype in RBRC06327
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1016054
• decreased epididymal fat pad weight in RBRC06327
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1009829
• decreased body weight in RBRC06327
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1009822
• decreased circulating leptin level in RBRC06327
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1009827
• abnormal digestion in RBRC06327
  http://metadb.riken.jp/db/rikenbrc_mouse/Phenotype_1009823

article

http://www.w3.org/2000/01/rdf-schema#seeAlso

• [Blank]

allele

http://purl.org/net/cito/citesAsAuthority

• Ffar3<tm1Reh>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3829251

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased triglyceride level_Ffar3<tm1Reh>/Ffar3<tm1Reh>
  http://metadb.riken.jp/0005318I129S6SvEvTacC57BL6JFfar3tm1RehFfar3tm1RehFfar3tm1Reh
• decreased epididymal fat pad weight_Ffar3<tm1Reh>/Ffar3<tm1Reh>
  http://metadb.riken.jp/0009289I129S6SvEvTacC57BL6JFfar3tm1RehFfar3tm1RehFfar3tm1Reh
• abnormal energy homeostasis_Ffar3<tm1Reh>/Ffar3<tm1Reh>
  http://metadb.riken.jp/0005448I129S6SvEvTacC57BL6JFfar3tm1RehFfar3tm1RehFfar3tm1Reh
• decreased circulating leptin level_Ffar3<tm1Reh>/Ffar3<tm1Reh>
  http://metadb.riken.jp/0005668I129S6SvEvTacC57BL6JFfar3tm1RehFfar3tm1RehFfar3tm1Reh
• abnormal digestion_Ffar3<tm1Reh>/Ffar3<tm1Reh>
  http://metadb.riken.jp/0001664I129S6SvEvTacC57BL6JFfar3tm1RehFfar3tm1RehFfar3tm1Reh
• abnormal intestinal transit time_Ffar3<tm1Reh>/Ffar3<tm1Reh>
  http://metadb.riken.jp/0006001I129S6SvEvTacC57BL6JFfar3tm1RehFfar3tm1RehFfar3tm1Reh
• abnormal feces composition_Ffar3<tm1Reh>/Ffar3<tm1Reh>
  http://metadb.riken.jp/0003868I129S6SvEvTacC57BL6JFfar3tm1RehFfar3tm1RehFfar3tm1Reh
• decreased body weight_Ffar3<tm1Reh>/Ffar3<tm1Reh>
  http://metadb.riken.jp/0001262I129S6SvEvTacC57BL6JFfar3tm1RehFfar3tm1RehFfar3tm1Reh

article

http://www.w3.org/2000/01/rdf-schema#seeAlso

• [Blank]